Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Boston Scientific is a medical devices business based in the US. Boston Scientific stocks (BSX.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $48.33 – a decrease of 1.04% over the previous week. Boston Scientific employs 45,000 staff and has a trailing 12-month revenue of around $12.7 billion.
Finder Award
Interactive Brokers
National Bank Direct Brokerage
| Latest market close | $48.33 |
|---|---|
| 52-week range | $34.98 - $49.22 |
| 50-day moving average | $46.95 |
| 200-day moving average | $42.69 |
| Wall St. target price | $53.00 |
| PE ratio | 106.1739 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.46 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $48.33 from 2023-03-27
| 1 week (2023-03-21) | -1.04% |
|---|---|
| 1 month (2023-02-28) | 3.45% |
| 3 months (2022-12-28) | 5.57% |
| 6 months (2022-09-28) | 23.51% |
| 1 year (2022-03-25) | 11.10% |
|---|---|
| 2 years (2021-03-26) | 26.45% |
| 3 years (2020-03-27) | 57.89% |
| 5 years (2018-03-28) | 81.15% |
Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $12.7 billion |
|---|---|
| Operating margin TTM | 16.03% |
| Gross profit TTM | $8.7 billion |
| Return on assets TTM | 3.93% |
| Return on equity TTM | 4.08% |
| Profit margin | 5.5% |
| Book value | $12.26 |
| Market capitalisation | $70.1 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 29.23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 01/01/2019) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.51/100
Social score: 12.87/100
Governance score: 7.87/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.
We're not expecting Boston Scientific to pay a dividend over the next 12 months.
Boston Scientific's shares were split on a 2:1 basis on 6 November 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific shares which in turn could have impacted Boston Scientific's share price.
Over the last 12 months, Boston Scientific's shares have ranged in value from as little as $34.98 up to $49.22. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.7853. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…Everything we know about the Neuraxis IPO plus information on how to buy in.
Everything we know about the Brera IPO plus information on how to buy in.
Everything we know about the TXO Energy IPO plus information on how to buy in.
Your guide to how ETFs work and whether this type of investment is right for you.
Steps to owning and managing TXG stock, with 24-hour and historical pricing before you buy.
The best stock trading app for beginners is easy to use and offers free trades.
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
An healthcare company, NFT tech developer and baby products retailer are among the IPOs expected to take place this month.
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
The best time to buy stocks could be right after an IPO, during expansion periods or when other investors are buying or selling.
